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Palytoxin (PLTX) and its analogues have been detected as seafood contaminants and 27	  
associated with a series of human foodborne poisonings. Due to some fatalities ascribed to the 28	  
ingestion of PLTX-contaminated marine organisms, the development of methods for its 29	  
detection in seafood is recommended by the European Food Safety Authority (EFSA). Due to 30	  
its feasibility, the spectrophotometric hemolytic assay is widely used to detect PLTX in 31	  
different matrices, even though a standardized protocol is still lacking. 32	  
Thus, on the basis of available assay procedures, a new standardized protocol was set up 33	  
using purified human erythrocytes exposed to PLTX (working range: 3.9x10-10-2.5x10-8 M) in 34	  
a K+-free phosphate buffered saline solution, for 5 h at 41°C. An intra-laboratory 35	  
characterization demonstrated its sensitivity (limit of detection, LOD=1.4x10-10 M and 36	  
quantitation, LOQ=3.4x10-10 M), accuracy (bias=-0.8%), repeatability (RSDr=15% and 6% 37	  
for intra- and inter-day repeatability, respectively) and specificity. However, the standardized 38	  
method seems not to be suitable for PLTX quantitation in complex matrices, such as mussels 39	  
(Mytilus galloprovincialis) extracts, below the limit suggested by EFSA (30 µg PLTXs/Kg 40	  
shellfish meat). Thus, the hemolytic assay for PLTX quantitation in seafood should be used 41	  
only after a careful evaluation of the specific matrix effects. 42	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1. Introduction 47	  
Palytoxin (PLTX) is a highly toxic non-polymeric complex molecule, originally isolated from 48	  
zoanthids of the genus Palythoa (Moore and Scheuer, 1971), and later identified in benthic 49	  
dinoflagellates of the genus Ostreopsis and cyanobacteria of the genus Trichodesmium 50	  
(Ciminiello et al., 2008; Kerbrat et al., 2011). Over the years, several PLTX analogues have 51	  
been detected in different marine organisms, including: (i) Ostreocin-D (Ost-D) in Ostreopsis 52	  
siamensis (Usami et al., 1995); (ii) two stereoisomers of 42-hydroxy-PLTX (42-OH-PLTX), 53	  
differing only for the configurational inversion at C50, identified in Palythoa toxica and P. 54	  
tuberculosa (Ciminiello et al.,2014a); and (iii) ovatoxin-a (OVTX-a), the major toxin 55	  
produced by Ostreopsis cf. ovata in the Mediterranean Sea (Ciminiello et al., 2012). In 56	  
addition, a series of OVTX-a analogues have been identified, such as OVTX-b to -k and 57	  
isobaric palytoxin (Brissard et al., 2015; García-Altares et al., 2015; Tartaglione et al., 2016).  58	  
These toxins may enter the human food chain through their accumulation into different 59	  
marine edible organisms, such as fishes, crustaceans, bivalves, gastropods, cephalopods, 60	  
echinoderms, sponges and polychaete worms (Aligizachi et al., 2011; Biré et al., 2013; Gleibs 61	  
and Mebs, 1999). In particular, a series of human poisonings characterized by general 62	  
malaise, myalgia, cardiac problems, respiratory distress, and sometimes death, have been 63	  
ascribed to the ingestion of PLTX-contaminated fishes and crabs in tropical areas (Deeds and 64	  
Schwartz, 2010; Tubaro et al., 2011b; Wu et al., 2014).  65	  
In recent years, microalgae belonging to the genus Ostreopsis have frequently bloomed in the 66	  
temperate Mediterranean Sea and the relevant toxins (mainly OVTX-a) have been detected in 67	  
microalgae, aerosolized seawater and some marine edible organisms. However, no foodborne 68	  
poisonings associated with PLTXs have yet been documented in this area, so far (Biré et al., 69	  
2013; Ciminiello et al., 2014a; Del Favero et al., 2012).  70	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Although there is no official regulation for PLTXs in seafood, the European Food Safety 71	  
Authority (EFSA) suggested a maximum limit of 30 µg PLTXs/Kg of shellfish meat, and 72	  
recommended the development of specific, rapid, precise and accurate methods for PLTXs 73	  
quantitation in seafood during monitoring programs (EFSA, 2009). Despite several methods 74	  
for PLTXs detection have been already published (Riobò et al., 2011; Tubaro et al., 2014), 75	  
they are not completely validated to be officially accepted, frequently requiring expensive 76	  
equipments and highly qualified operators, and/or presenting limitations in terms of 77	  
sensitivity, specificity and matrix effects.  78	  
Among them, the delayed hemolytic assay is one of the most used screening methods for 79	  
PLTX quantitation, due to its simplicity, cheapness, rapidity and sensitivity. It is based on the 80	  
toxin ability to convert the Na+/K+ ATPase of mammal erythrocytes to a nonspecific cationic 81	  
channel, leading to a rapid loss of K+ ions from cells and a delayed hemoglobin release that 82	  
can be easily measured spectrophotometrically (Habermann et al., 1981). The hemolytic assay 83	  
is usually carried out following the Bignami’s protocol (1993) with or without modifications, 84	  
but a standardized and universally accepted procedure has not been defined, so far. Most 85	  
literature studies report the original assay with a series of modifications mainly concerning 86	  
the origin of erythrocytes, the time and temperature of their incubation with PLTX, and/or the 87	  
working buffer composition (Aligizaki et al., 2008; Biré et al., 2013; Brissard et al., 2014; 88	  
Gleibs et al., 1995; Kim et al., 2002; Lenoir et al., 2004; Malagoli, 2007; Onuma et al., 1999; 89	  
Pezzolesi et al., 2012; Riobò et al., 2006; Riobò et al., 2008; Taniyama et al., 2001; Taniyama 90	  
et al., 2003; Volpe et al., 2014; Wachi and Hokama, 2001). Due to these experimental 91	  
variables, a standardized protocol for the hemolytic assay to be considered as a reference 92	  
procedure in PLTX quantitation is still lacking. 93	  
Moreover, edible marine species could contain hemolytic compounds different from PLTXs, 94	  
tentatively interfering with the assay giving false positive results. For instance, a recently 95	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developed biosensor to quantify PLTX in mussels, based on lactate dehydrogenase release 96	  
from sheep erythrocytes, appeared to be influenced by a significant mussels matrix effect and 97	  
low PLTX recovery (Volpe et al., 2014). Thus, the accuracy and precision of the hemolytic 98	  
assay for spectrophotometric PLTX quantitation in shellfish needs to be properly evaluated. 99	  
Hence, this study was carried out to set up a novel standardized protocol for the hemolytic 100	  
assay useful as reference procedure and to characterize its suitability for PLTX quantitation in 101	  
mussels (Mytilus galloprovincialis), often heavily contaminated by PLTXs (Brissard et al., 102	  
2014; Aligizaki et al., 2008; Aligizaki et al., 2011; Amzil et al., 2012). 103	  
 104	  
2. Materials and methods 105	  
2.1 Toxins and other materials 106	  
PLTX was purchased from Wako Pure Chemicals Industries Ltd. (Osaka, Japan; purity > 90 107	  
%). 42S-hydroxy-50S-palytoxin and 42S-hydroxy-50R-palytoxin were isolated from Palythoa 108	  
tuburculosa and P. toxica, as previously reported (Ciminiello et al., 2009; Ciminiello et al., 109	  
2014b). Ovatoxin-a and the mixture of ovatoxin-a,-d,-e were kindly provided by Prof. P. 110	  
Ciminiello (Università di Napoli “Federico II”, Naples, Italy). The mouse monoclonal anti-111	  
PLTX antibody 73D3 (mAb-PLTX) was produced by a hybridoma cell culture, as previously 112	  
described (Bignami et al., 1992). All the other reagents were of analytical grade and 113	  
purchased from Sigma-Aldrich (Milan, Italy), if not otherwise specified.  114	  
 115	  
2.2 Red blood cell purification 116	  
Blood samples from healthy human volunteers were obtained from the Transfusion Center, 117	  
Azienda Ospedaliera Universitaria, Trieste, Italy. All donors signed an approved consent form 118	  
giving permission for the collection and use of blood for research purposes (WMA 119	  
Declaration of Helsinki). Blood was drawn by venipuncture between 08.00 a.m. and 10.00 120	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a.m. to minimize variability due to circadian rhythms, and immediately processed. Blood, 121	  
collected into standard triple bag systems, was fractionated following standard procedures to 122	  
obtain buffy-coats, used to purify red blood cells. Buffy coats (50 ml) were diluted 1:1 (v/v) 123	  
in the erythrocytes preservation solution (specified in section 2.3) and then centrifuged at 124	  
2400 rpm for 10 min at 4 °C. Red blood cells pellet (2 ml), suspended in the red blood cells 125	  
preservation solution (10 ml), was washed three times by centrifugation at 1500 rpm for 5 min 126	  
at 15 °C. Then, the final pellet was re-suspended 1:10 (v/v) in the preservation solution.  127	  
 128	  
2.3 Red blood cells storage 129	  
Three storage solutions were used to evaluate red blood cells preservation at 4° C: Saline-130	  
Adenine-Glucose-Mannitol solution (SAGM, containing 5x10-2 M dextrose, 0.15 M NaCl, 131	  
2.4x10-3 M adenine and 2.9x10-2 M d-mannitol) (Zehnder et al., 2008), Adenine-Dextrose 132	  
Solution (ADSOL, containing 0.12 M dextrose, 0.15 M NaCl, 3.9x10-3 M adenine and 4.1x10-133	  
2 M d-mannitol) (Moore, 1991) and Dulbecco’s Phosphate Buffered Saline (D-PBS) 134	  
containing 1mM ethylenediaminetetracetic acid (EDTA) and 5 mM glucose (Lowe et al., 135	  
1973). Red blood cells preservation was evaluated by means of erythrocyte resistance to 136	  
spontaneous lysis and erythrocyte concentration. For the first parameter, 0.4 ml of red blood 137	  
cells suspension was centrifuged at 1500 rpm for 5 min and the optical density of the 138	  
supernatant was then measured at 405/540 nm (Microplate autoreader; Bio-Tek Instruments; 139	  
Vinooski, VT). Red blood cell concentration was evaluated by cell counting following the 140	  
Trypan Blue Exclusion Test. Acceptable thresholds were constant cells concentration and 141	  
optical densities lower than 0.5, a value close to the average optical densities of the negative 142	  
controls (125 µl of red blood cell suspension incubated with K+-free D-PBS without toxin). 143	  




2.4 Experimental design 146	  
The hemolytic assay was standardized considering the following parameters: the use of 147	  
purified human erythrocytes vs whole blood, the influence of selected ions (borates, calcium, 148	  
sodium, and potassium) on PLTX-induced hemolysis, and the incubation temperature of 149	  
erythrocytes exposed to PLTX. The standardized assay was subsequently characterized 150	  
according to the international principles, as described by the Eurachem Guide (Magnusson 151	  
and Örnemark, 2014). 152	  
 153	  
2.5 Standardized hemolytic assay 154	  
After washing, red blood cells were pelleted by centrifugation (1500 rpm for 5 min) and re-155	  
suspended in K+-free D-PBS at the concentration of 1x108 cells/ml. In 96-wells plates, 125 µl 156	  
of PLTX solution and 125 µl of the erythrocytes suspension were added to each well and 157	  
incubated for 5 h at 41 °C (PLTX final concentrations: 1.22x10-11-4.00x10-7 M). As negative 158	  
controls, 125 µl of red blood cell suspension were incubated with 125 µl K+-free D-PBS 159	  
without toxin. As a positive control, 100% hemolysis was achieved by incubating the 160	  
erythrocytes suspension with 125 µl of 0.1% Tween 20 (v/v) for 5 h at 41° C. After 161	  
incubation, the plate was centrifuged at 1500 rpm for 5 min at 15 °C and, using a 162	  
multichannel pipette, the supernatant was carefully transferred into a clear flat bottom 96-163	  
wells plate avoiding pellet braking up. Optical density (O.D.) of supernatant was then 164	  
measured at 405/540 nm and the percentage of hemolysis calculated with respect to the 165	  
positive control by the following formula:  166	  
% of hemolysis = 100 x (O.D. PLTX exposed sample−O.D. negative control)/(O.D. positive 167	  
control – O.D. negative control). 168	  
 169	  
2.6 Evaluation of the matrix effect 170	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To assess the hemolytic assay suitability to quantify PLTX in mussels at levels below the 171	  
suggested EFSA limit (30 µg PLTXs/kg edible parts, corresponding to about 11.2x10-9 172	  
mol/kg; EFSA, 2009), different extracts of Mytilus galloprovincialis edible parts were 173	  
prepared. Each extract was analyzed by liquid chromatography high resolution mass 174	  
spectrometry (LC-HRMS) to verify the absence of PLTX before the matrix effect evaluation. 175	  
Mussels were collected in the Gulf of Trieste (Italy) and shucked meat (200 g) was 176	  
homogenized (14000 rpm, 3 min) using an Ultra-Turrax (Ika-Werk; Staufen, Germany). The 177	  
homogenate (1 g) was extracted three times with 3 ml of different solvents (80%, 50% or 20% 178	  
aqueous ethanol or aqueous methanol). Each extractive solution was then centrifuged at 5500 179	  
rpm for 30 min, the corresponding supernatants were pooled and the volumes adjusted to 10 180	  
ml with the relevant extraction solvents to obtain six extracts at a final concentration of 0.1 g 181	  
mussels meat equivalents/ml. The hemolytic activity of each extract was then evaluated at 182	  
five dilutions (1:1, 1:10, 1:50, 1:100 and 1:1000, v/v) to assess background hemolysis.  183	  
At dilutions devoid of background hemolysis, extracts were spiked with different PLTX 184	  
concentrations to prepare matrix matched-samples at PLTX levels ranging from 3.9x10-10 to 185	  
2.5x10-8 M. These matched samples were then analyzed using the hemolytic assay. The 186	  
relevant hemolytic activity was compared to that induced by the same PLTX concentrations 187	  
without matrix. 188	  
 189	  
2.7 Statistical analyses 190	  
Results of the hemolytic assay are presented as mean±SE of at least three independent 191	  
experiments performed in triplicate. Linearity (r2) of the calibration curve was estimated by 192	  
linear regression analysis, using the GraphPad Prism software version 5.0 (GraphPad Prism; 193	  
GraphPad Software, Inc.; San Diego, CA). Concentration-effect curves were compared by 194	  
two-way ANOVA statistical analysis and Bonferroni post test, and significant differences 195	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were considered at p < 0.05. EC50 (effective concentration giving 50% hemolysis) was 196	  
calculated by nonlinear regression using a four parameters curve-fitting algorithm of the 197	  
GraphPad Prism software.  198	  
Hemolytic assay performance was characterized according to the international principles 199	  
described by the Eurachem Guide (Magnusson and Örnemark, 2014). Briefly, limit of 200	  
detection (LOD) and quantitation (LOQ) were expressed as PLTX concentration 201	  
corresponding to the average of 10 blank values plus 3 or 10 times the standard deviations, 202	  
respectively. Accuracy was measured as % Bias (n = 10), calculated as % difference between 203	  
PLTX concentration measured by the assay and the theoretical concentration in the sample 204	  
divided by PLTX theoretical concentration. Repeatability was expressed as relative standard 205	  
deviation of repeatability (RSDr), measured as % ratio between the standard deviation of 206	  
independent results and their mean value. Both independent results obtained by the same 207	  
operator in one day (intra-assay RSDr; n = 10) and within a 6-month period by different 208	  
operators (inter-assay RSDr; n = 10) were considered.  209	  
 210	  
3. Results and discussion 211	  
 212	  
3.1 Storage of purified human erythrocytes 213	  
The human erythrocytes model was chosen due to the easy availability of human blood, rapid 214	  
isolation of significant cell numbers, and low cost. The use of purified human erythrocytes 215	  
poses the need of a medium suitable to preserve the cells. To this aim, three cells storage 216	  
solutions were evaluated: Saline-Adenine-Glucose-Mannitol Solution (SAGM), Adenine-217	  
Dextrose Solution (ADSOL) and D-PBS containing 1 mM EDTA and 5 mM glucose (PBS-218	  
EDTA-glucose), as described in section 2.3 (Lowe et al., 1973; Moore, 1991; Zehnder et al., 219	  
2008). Erythrocytes preservation in these solutions was daily evaluated, monitoring two 220	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parameters up to 36 days: the spontaneous hemolysis (measured spectrophotometrically as 221	  
hemoglobin release) and the erythrocytes concentration determined by visual cell counting. 222	  
Acceptable thresholds were constant cell concentration in the storage solution and optical 223	  
densities lower than 0.5. Only PBS-EDTA-glucose solution allowed mainteinance of red 224	  
blood cells suitable for the assay for up to 3 weeks (Fig. S1), probably due to the presence of 225	  
crucial constituents providing the proper energy source to erythrocytes (glucose) and 226	  
preventing coagulation (EDTA). Hence, these conditions allow to prepare a batch of human 227	  
erythrocytes suitable for the hemolytic assay up to 3 weeks, reducing the working time and 228	  
avoiding to purify the erythrocytes before each single experiment.  229	  
 230	  
3.2 Optimization of the hemolytic assay 231	  
The hemolytic assay was standardized considering different experimental parameters reported 232	  
by previous published studies. In the first series of experiments, the hemolytic assay was 233	  
carried out following the most recent published method, using human erythrocytes (Malagoli, 234	  
2007). Following Malagoli’s protocol, the sensitivity of purified human erythrocytes to 235	  
PLTX-induced hemolysis was compared to that of the whole human blood. The hemolytic 236	  
activity of PLTX (7.8x10-10-5.0x10-8 M) towards purified human erythrocytes was 237	  
significantly higher than that displayed by the whole human blood: 65% and 7% hemolysis 238	  
were recorded at 5.0x10-8 M PLTX, respectively (Fig. 1A).  239	  
Previous studies demonstrated that borates, as H3BO3 or Na2B4O7 (> 5.0x10-6 M), and calcium 240	  
ions (> 2.0x10-5 M) in the buffer solution increases PLTX-induced hemolysis, probably by 241	  
promoting the interaction between the toxin and its molecular target, the Na+/K+ ATPase 242	  
(Ahnert-Hilger et al., 1982; Habermann, 1983). Thus, the influence of these factors on PLTX-243	  
induced lysis of purified erythrocytes was evaluated. As shown in Fig. 1B, no significant 244	  
differences in PLTX-induced hemolysis were observed between buffer solution containing 1 245	  
12	  
	  
mM H3BO3 and that containing 1 mM Na2B4O7, in agreement with literature data, where 246	  
H3BO3 or Na2B4O7 are interchangeably used. Regarding Ca2+ ions, no significant differences 247	  
were recorded between PLTX-induced hemolysis in D-PBS with or without CaCl2 (Fig. 1C). 248	  
However, the Ca2+ concentration in D-PBS solution (137 mM) is higher than that (>20 µM) 249	  
reported to promote the interaction between the toxin and its target (Ahnert-Hilger et al., 250	  
1982). Thus, additional Ca2+ ions at millimolar concentrations in the D-PBS buffer solution 251	  
containing 1mM H3BO3 are not necessary to increase PLTX hemolytic activity.  252	  
Based on the mechanism of action of the toxin (i.e. interaction with the Na+/K+ ATPase), the 253	  
influence of Na+ and K+ ions on PLTX-induced hemolysis was also evaluated. The presence 254	  
of Na+ ions (1.8x10-4M or 3.6x10-4M NaCl) in the buffer solution was associated to a 255	  
significant reduction of PLTX-induced hemolysis, probably due to the medium hypertonicity 256	  
causing erythrocytes shrinking and volume reduction (Kregenow, 1971) (Fig. 1D). In 257	  
contrast, while the K+-free buffer containing H3BO3 did not significantly influence the 258	  
hemolytic activity of PLTX, the latter was significantly increased using K+-free buffer 259	  
without H3BO3 (Fig. 1E).  260	  
Finally, the temperature influence on the hemolytic activity was evaluated. After erythrocytes 261	  
incubation with PLTX for 5 h at 41 °C, hemolysis was significantly higher than that recorded 262	  
at 37°C, with EC50 values of 6.2x10-9 M (95% confidence intervals, CI = 5.3 - 7.2x10-9 M) 263	  
and 4.9x10-8 M (95% CI = 4.1 – 5.9x10-8 M), respectively (Fig. 1F). This result is in 264	  
agreement to that reported by Habermann et al. (1981), suggesting that PLTX-induced 265	  
hemolysis is temperature-dependent.  266	  
On the whole, these results allowed to optimize a protocol for the hemolytic assay, using 267	  
purified human erythrocytes exposed to PLTX in a K+-free D-PBS buffer at 41 °C for 5 h. 268	  
 269	  
3.3 Characterization of the hemolytic assay 270	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3.3.1 Calibration curve for PLTX 271	  
Using the standardized hemolytic assay, the calibration curve for PLTX represented in Fig. 272	  
2A was obtained. The working range for PLTX detection was 3.9x10-10 -  2.5x10-8 M, with a 273	  
limit of detection (LOD) and quantitation (LOQ) of 1.4x10-10 M and 3.4x10-10 M, 274	  
respectively. Analyzing the working range by linear regression, plotting the theoretical toxin 275	  
concentrations against the PLTX concentrations measured by the hemolytic assay, a good 276	  
correlation coefficient was found (r2 = 0.9979; n = 10) (Fig. 2B). A mean Bias value (%) of -277	  
0.8% (range: -2.0% to 2.4%) highlights the accuracy of the measures (Table 1).  278	  
Intra-assay and inter-assay repeatability were then evaluated. A good correlation was 279	  
observed, with r2 values of 0.9736 for intra-assay (Fig. 3A) and 0.9977 for inter-assay 280	  
repeatability (Fig. 3B). These data were confirmed by the intra-day and inter-day repeatability 281	  
coefficients (relative standard deviation of repeatability, RSDr) of 15% (n=10) and 6% (six 282	  
months period, n=10), respectively (Table 1).  283	  
The haemolytic effect of PLTX in these conditions (described in section 3.2; 94% hemolysis 284	  
at 2.5x10-8 M) is much higher than that reported by Malagoli (2007) and Taniyama (2001): 285	  
they recorded a maximum hemolysis lower than 50% at the highest tested PLTX 286	  
concentrations (i.e. 103 and 102 ng PLTX/ml, corresponding to 3.7x10-6 M and 3.7x10-7 M 287	  
PLTX, respectively). These concentrations were 1 to 2 orders of magnitude higher than the 288	  
highest concentration of the assay working range presented in this study (i.e. 2.5x10-8 M, 289	  
giving 94% of hemolysis). Thus, an improved PLTX-induced hemolysis was achieved by 290	  
lowering the osmolarity of the working buffer (K+ ions withdrawal) and increasing the assay 291	  
temperature (41°C) in the optimized hemolytic assay protocol. 292	  
 293	  
3.3.2 Cross-reactivity with PLTX analogues 294	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The hemolytic assay was then evaluated for its ability to detect some PLTX analogues and N-295	  
biotinyl-PLTX within the working range set up for PLTX (3.9x10-10 -  2.5x10-8 M). Although 296	  
the hemolytic activity of nanomolar concentrations of 42S-OH-50S-PLTX (from P. toxica) 297	  
was slightly lower than that of the same PLTX concentrations, its hemolytic potency (EC50 = 298	  
5.8x10-9 M, 95% CI =  4.1 - 8.2x10-9 M) was comparable to that of PLTX (EC50 = 6.2x10-9 M, 299	  
95% Cl = 5.3x10-9 - 7.2x10-9 M) (Fig. 4). The latter result is in agreement with a previous 300	  
study demonstrating a similar hemolytic activity of the two compounds, using mouse 301	  
erythrocytes (Tubaro et al., 2011a). On the other hand, hemolysis induced by 42S-OH-50R-302	  
PLTX (stereoisomer from P. tuberculosa) was significantly lower than that of PLTX (Fig. 4), 303	  
in agreement with its lower cytotoxic effects, previously observed on HaCaT cells (Ciminiello 304	  
et al., 2014b). Also the hemolytic activity of pure OVTX-a and of a mixture of OVTXs 305	  
(OVTX-a, -d and –e) was significantly lower than that of PLTX, similarly to their cytotoxicity 306	  
toward skin keratinocytes, as recently demonstrated by Pelin et al. (2016). In contrast, the 307	  
latter result is not in agreement with other studies hypothesizing that PLTX and OVTXs 308	  
possess similar hemolytic activity (Brissard et al., 2014; Pezzolesi et al., 2012). However, 309	  
since these studies were carried out using sea urchins and Ostreopsis ovata extracts 310	  
containing OVTX analogues other than OVTX-a, -d and –e as well as isobaric PLTX 311	  
(Brissard et al., 2014; Pezzolesi et al., 2012), we can speculate that those  mixtures of toxins 312	  
could display a hemolytic activity different than that of OVTX-a or of the other single 313	  
OVTXs. Moreover, since complete studies on this matrices were not carried out, a significant 314	  
interference of the extract’s matrix cannot be excluded.  315	  
In addition, the hemolytic potency of a semisynthetic PLTX derivative, biotinylated PLTX, 316	  
was significantly lower than that of PLTX, inducing only 5% hemolysis at the highest 317	  
concentration (2.5x10-8 M). Intriguingly, a biotin linked to the terminal PLTX amino group 318	  
reduces PLTX-induced hemolysis, indicating the importance of the primary amine for the 319	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hemolytic effect via Na+/K+-ATPase interaction. This finding is in agreement with previous 320	  
evidences for N-acetyl-PLTX which biological activity via Na+/K+-ATPase were over 100 321	  
times weaker than those of the parent compound PLTX, tentatively due to a change in the 322	  
global toxin conformation that prevents its dimerization (Kudo and Shibata, 1980; Ohizumi 323	  
and Shibata, 1980; Inuzuka et al., 2008). Moreover, this result suggests that the functional 324	  
hemolytic assay detects only biologically active PLTX analogues. In contrast, other non-325	  
functional analytical methods can detect also biologically inactive PLTX-like compounds 326	  
(Boscolo et al., 2013), which might not contribute the whole toxic potential of PLTXs-327	  
contaminated seafood samples.  328	  
In conclusion, these results demonstrated that the hemolytic assay has a good sensitivity for 329	  
PLTX and 42S-OH-50S-PLTX from P. toxica. On the contrary, the stereoisomer 42S-OH-330	  
50R-PLTX from P. tuberculosa, as well as OVTX-a and OVTXs mixture have lower 331	  
hemolytic activity. Anyway, all the tested natural PLTX analogues exert hemolytic effects, 332	  
which suggest a common mechanism of action.  333	  
 334	  
3.3.3 Hemolysis neutralization 335	  
It is known that the cardiac glycoside ouabain, which binds to the same molecular target of 336	  
PLTX, inhibits the in vitro effects of PLTX (Habermann and Chhatwal, 1982; Pelin et al., 337	  
2013). Thus, to confirm the specific delayed hemolysis by PLTXs, excluding a possible 338	  
hemolysis by other constituents of seafood samples, the standardized assay was carried out 339	  
pre-incubating the red blood cells with 100 µM ouabain for 30 min at 37 °C (Aligizaki et al., 340	  
2008; Biré et al., 2013; Brissard et al., 2014; Gleibs et al., 1995; Malagoli, 2007; Onuma et 341	  
al., 1999; Pezzolesi et al., 2012; Riobo et al., 2006; Riobo et al., 2008; Taniyama et al., 2001; 342	  
Taniyama et al., 2003; Volpe et al., 2014). Similarly, the mouse monoclonal anti-PLTX 343	  
antibody (mAb-PLTX, 50 µg/ml) was used to neutralize the hemolysis induced by PLTX. The 344	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PLTX induced hemolysis was completely inhibited by ouabain and only partially by the 345	  
mAb-PLTX (Fig. 5), in agreement with previous findings reported by Bignami (1993). 346	  
 347	  
3.4 Matrix effect 348	  
To assess the interference of mussel matrix on PLTX-induced hemolysis, different extracts of 349	  
Mytilus galloprovincialis were prepared. Firstly, 80%, 50% and 20% aqueous methanol and 350	  
ethanol extracts of toxin-free mussels were tested after 1:1, 1:10, 1:50, 1:100 and 1:1000 (v/v) 351	  
dilutions, to verify whether the matrix (mussel extracts) could produce false positive results. 352	  
All the aqueous ethanol extracts required dilutions higher than 1:100 to avoid matrix effects in 353	  
the hemolytic assay (Fig. S2). On the other hand, no significant interferences were recorded 354	  
for the 80% aqueous methanol extract at 1:50 dilution or 50% and 20% aqueous methanol 355	  
extracts at 1:10 dilution (Fig. S3). Thus, the subsequent studies were carried out using the 356	  
aqueous methanol extracts at these dilutions. Specifically, 80% aqueous methanol extract 357	  
(1:50), as well as 50% and 20% aqueous methanol extracts (1:10) were spiked with known 358	  
amounts of PLTX (final concentrations ranging from 3.9x10-10 M to 2.5x10-8 M). Then, the 359	  
spiked extracts were analyzed by the hemolytic assay in comparison to the same PLTX 360	  
concentrations without matrices. The extract which did not interfere with the hemolytic assay 361	  
was the 80% aqueous methanol extract diluted 1:50 (Fig. S4). Notably, this extraction method 362	  
is the most suitable for PLTX extraction from mussels, giving 90-100% toxin recovery, by 363	  
LC-HRMS and a sandwich ELISA (Ciminiello et al., 2011; Boscolo et al., 2013). Thus, 80% 364	  
aqueous methanol at 1:50 dilution was subsequently used for the matrix effect study. 365	  
Fig. 6 shows the results of the linear regression analysis carried out comparing the theoretical 366	  
PLTX concentrations in the spiked extract to those measured by the hemolytic assay. The 367	  
LOQ for PLTX in the mussels extract was 1.3 ng/ml, corresponding to 13 µg/kg meat. 368	  
Considering the 1:50 dilution, the LOQ for PLTX in mussels corresponds to 640 µg/kg meat, 369	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a value about 20 times higher than the maximum limit suggested by EFSA (30 µg PLTXs/kg 370	  
meat). Moreover, the linear regression analysis yielded a correlation coefficient (r2 = 0.9259) 371	  
and a Bias range from -27.0 to 33.6% (mean Bias = 3.7%, Table 2) index of high dispersion 372	  
of the data, suggesting low accuracy and precision of the measurement. Thus, the 373	  
standardized and characterized hemolytic assay suffers from a significant mussel matrix 374	  
effect, which does not allow PLTX quantitation in Mytilus galloprovincialis at concentrations 375	  
lower than that proposed by EFSA. Interestingly, a significant interference by mussels matrix 376	  
was recently observed also for a biosensor exploiting lactate dehydrogenase (LDH) release 377	  
from sheep erythrocytes as hemolysis parameter to quantify PLTX (Volpe et al., 2014): 378	  
similarly to our study, due to the significant matrix effect, a 1:50 dilution of the mussels 379	  
extract was required to quantify PLTX in mussels, not meeting the EFSA requirements 380	  
(Volpe et al., 2014). Intriguingly, the observed interference of the mussels extract is not due 381	  
to the solvent used for extraction (i.e. 80% aqueous methanol) since the relevant mussels-free 382	  
solvent did not induce hemolysis (data not shown). On the contrary, low dilutions of mussels 383	  
methanol extract (i.e. 1:1 or 1:10, Fig. S3) displayed an increased hemolytic activity as 384	  
compared to that of higher extract dilutions, sometimes comparable to that of the positive 385	  
control (0.1% Tween 20). Hence, the significant matrix effect could be due to hemolytic 386	  
compounds different from PLTX, that could be at least partially extracted from mussels by 387	  
aqueous methanol. Indeed, a series of potentially hemolytic compounds, such as 388	  
glycoglycerolipids, lysophospholipids and unsaturated fatty acids, are known constituents of 389	  
mussel edible parts. The concentration of these compounds in mussel meat could be also 390	  
influenced by season, living site of mussels, dietary composition of phytoplankton as well as 391	  
temperature and enzymes action during transportation and storage of seafood (Colles and 392	  
Chisolm, 2000; Facchini et al., 2016; Ginsburg et al., 1989; Parrish et al., 1998; Pleissner et 393	  
al., 2012). 394	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All together, these results suggest that PLTX-induced erythrocytes lysis is not a suitable 395	  
endpoint for the toxin quantitation in mussels. In addition, since the hemolytic assay has been 396	  
worldwide used to detect PLTXs in different field marine samples (also concomitantly to 397	  
potential human poisonings ascribable to PLTXs), those data should be carefully considered 398	  
because of possible matrices effect that could have affected the analytical outcomes. 399	  
 400	  
4. Conclusions 401	  
In conclusion, this hemolytic assay employing purified human erythrocytes is characterized 402	  
by a good sensitivity, accuracy, specificity and repeatability. However, it does not allow any 403	  
PLTX quantitation in mussels (Mytilus galloprovincialis) at concentrations below the 404	  
maximum limit suggested by EFSA (30 µg/kg; EFSA, 2009), due to the high matrix 405	  
interference. In fact, hemolytic substances different from PLTX could be extracted from 406	  
mussels together with PLTX (Colles and Chisolm, 2000; Facchini et al., 2016; Ginsburg et 407	  
al., 1989; Parrish et al., 1998; Pleissner et al., 2012), causing false positive results. Thus, the 408	  
hemolytic assay for PLTX quantitation in seafood could be used only after a careful 409	  
evaluation of the specific matrix effects in each natural sample. 410	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Fig. 1. Optimization of the hemolytic assay. A: PLTX-induced hemolysis using whole human 608	  
blood or purified human erythrocytes. B: PLTX-induced hemolysis on human erythrocytes in 609	  
presence of 1 mM boric acid or 1 mM sodium tetraborate. C: PLTX-induced hemolysis on 610	  
human erythrocytes with and without 1 mM CaCl2. D: PLTX-induced hemolysis on human 611	  
erythrocytes with and without 1.8x10-4M or 3.6x10-4M NaCl, 2x or 4x. E: PLTX-induced 612	  
hemolysis on human erythrocytes with and without K+ ions (2.7 mM KCl, 8.1 mM KH2PO4). 613	  
F: PLTX-induced hemolysis on human erythrocytes at 37° C and 41° C. Each point represents 614	  
the mean ± SE of 3 different experiments.*p <0.05; **p < 0.01; ***p < 0.001 (for D and E as 615	  
compared to PBS + H3BO3 + NaCl 1x; two-way ANOVA and Bonferroni post test). 616	  
 617	  
Fig. 2. A: Calibration curve of the hemolytic assay for PLTX. Each point represents the mean 618	  
± SE of ten different experiments. B: Linear regression analysis performed within the working 619	  
range of the hemolytic assay (3.9x10-10 M - 2.5x10-8 M) by plotting the theoretical PLTX 620	  
concentrations against the toxin concentrations measured by the hemolytic assay (n = 10). 621	  
 622	  
Fig. 3. Repeatability of the hemolytic assay. Linear regression analysis performed within the 623	  
working range of the hemolytic assay (3.9x10-10 M - 2.5x10-8 M) by plotting the theoretical 624	  
PLTX concentrations against toxin concentrations measured by the hemolytic assay. A: Intra-625	  
day repeatability (n = 10). B: Inter-day repeatability (six months period, n = 10). 626	  
 627	  
Fig. 4. Hemolytic activity of N-biotinyl-PLTX, PLTX and its natural analogues within the 628	  
working range for PLTX (3.9 x 10-10 M - 2.5x10-8 M). Each point represents the mean ± SE of 629	  
3 different experiments. *p <0.05; **p < 0.01; ***p < 0.001 as compared to PLTX (two-way 630	  




Fig. 5. Neutralization of PLTX-induced hemolysis within the working range of the hemolytic 633	  
assay (3.9x10-10 M -  2.5x10-8 M) by ouabain and anti-PLTX monoclonal antibody, mAb. 634	  
Each point represents the mean ± SE of 3 different experiments.*p <0.05; **p < 0.01; ***p < 635	  
0.001 as compared to PLTX (two-way ANOVA and Bonferroni post test).  636	  
 637	  
Fig. 6. Matrix effect. Linear regression analysis within the working range of the hemolytic 638	  
assay (3.9x10-10 M - 2.5x10-8 M) performed on 80% aqueous methanol mussels extracts 639	  
diluted 1:50. Linear regression analysis was performed within the working range of the 640	  
hemolytic assay (3.9x10-10 M - 2.5x10-8 M) by plotting the theoretical PLTX concentrations 641	  
against toxin concentrations measured by the hemolytic assay. 642	  
29	  
	  
Table 1. Bias values (%) for PLTX analysis and intra-day (n=10, 1 day) and inter-day (n=10, 643	  
6 months) relative repeatability (RSDr %).  644	  
 645	  
PLTX (M)  Bias (%) 
Intra-day repeatability Inter-day repeatability 
Mean RSDr % Mean RSDr % 
3.91x10-10 -1.2 4.55x10-10 17 3,86x10-10 10 
7.81x10-10 -1.7 7.60x10-10 12 7,68x10-10 3 
1.56x10-9 -2.0 1.63x10-9 20 1,53x10-9 8 
3.13x10-9 2.4 2.47x10-9 24 3,24x10-9 7 
6.25x10-9 0.3 6.51x10-9 12 6,27x10-9 3 
1.25x10-8 -1.4 1.28x10-8 8 1,24x10-8 7 











Table 2. Bias values (%) for PLTX detected in 80% aqueous methanol mussels extracts 649	  
spiked with the toxin after 1:50 dilution in comparison to the theoretical PLTX concentrations 650	  











  662	  











Figure 1 663	  
 664	  
  665	  
32	  
	  
Figure 2 666	  
 667	  
 668	  
Figure 3 669	  
 670	  
 671	  
  672	  
33	  
	  
Figure 4 673	  
 674	  
 675	  
Figure 5 676	  
 677	  
 678	  
  679	  
34	  
	  
Figure 6 680	  
 681	  
